News Novo's semaglutide outperforms Lilly GLP-1 rival If approved semaglutide could become set the standard for GLP-1 therapy
News Novo Nordisk may drop US insulin price as Sanofi suffers Biosimilar Lantus is causing rivals to cut prices to compete
News Novo Nordisk and Glooko launch diabetes management app New digital health partners Novo Nordisk and Glooko have released their first joint diabetes-focused app.
News Novo's Saxenda label to include cardio data Label will reflect heart benefit seen in LEADER trial.
News Biotech vTv believes small molecule GLP-1 pill can take on b... Pill could be effective in diabetes, with fewer GI effects.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
